# Taboola

Type: Company (TBLA)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/taboola
Canonical HTML page: https://getbiobrief.com/entity/taboola

## Recent coverage (1 stories)

### Alcon Navigates Q4 Earnings Miss as Ophthalmic Demand Shows Resilience
2026-02-25 16:40:00 · Sentiment: Neutral · Impact: 5/10 · Sources: 6

Alcon (ALC) reported Q4 2025 revenue of $2.7 billion and non-GAAP EPS of $0.78, both narrowly missing analyst estimates. Despite the slight financial shortfall, the eye care leader maintains a strong market position in surgical innovation and vision care products.
Full story: https://getbiobrief.com/story/alcon-q4-2025-earnings-analysis-ophthalmology

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.